Playback speed
10 seconds
Acalabrutinib vs. SoC for R/R CLL: Do the Final Results of ASCEND Trial Confirm Favorable Efficacy and Safety of the BTKi Option?
65 views
December 14, 2020
Comments 0
Login to view comments.
Click here to Login
Leukemia